A detailed history of Invesco Ltd. transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Invesco Ltd. holds 53,107 shares of BLCO stock, worth $961,236. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,107
Holding current value
$961,236
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$13.6 - $17.06 $722,255 - $906,005
53,107 New
53,107 $771,000
Q3 2023

Nov 13, 2023

SELL
$16.8 - $20.99 $301,408 - $376,581
-17,941 Reduced 25.2%
53,267 $902,000
Q2 2023

Aug 11, 2023

SELL
$16.03 - $20.07 $108,234 - $135,512
-6,752 Reduced 8.66%
71,208 $1.43 Million
Q1 2023

May 12, 2023

SELL
$15.67 - $18.91 $79,399 - $95,816
-5,067 Reduced 6.1%
77,960 $1.36 Million
Q4 2022

Feb 13, 2023

BUY
$13.5 - $17.14 $781,353 - $992,028
57,878 Added 230.14%
83,027 $1.29 Million
Q3 2022

Nov 14, 2022

BUY
$14.23 - $17.76 $357,870 - $446,646
25,149 New
25,149 $386,000

Others Institutions Holding BLCO

About Bausch & Lomb Corp


  • Ticker BLCO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 350,000,000
  • Market Cap $6.34B
  • Description
  • Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...
More about BLCO
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.